Insider Cluster (2 insiders) ·Filed Sep 4, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed28d 18h ago
Insider cluster: 2 insiders, $865K total
Actionable Insight • Neutral

The $865K in insider sales is immaterial relative to market cap and likely reflects routine portfolio diversification or tax planning. Monitor for any larger insider sales or a pattern of sustained selling by the CEO; standalone, this cluster does not signal a material bearish event.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
NTRA ▲ +4.15% at T+5d
NEUTRAL call ✓ call won +4.15% · α vs SPY +5.36% · entry $328.18 → $341.79
Next anchor: T+20d due 8h ago
Latest observation: T+18 +13.36% FF3 residual α
Entry anchored
Sep 3, 2026
via day open
T+1d
-1.23%
call -1.23% · α -0.68%
$324.14
settled 28d ago
T+5d
+4.15%
call +4.15% · α +5.36%
$341.79
settled 21d ago
T+20d
—
call — · α —
—
due 8h ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Two top executives at Natera — CEO Steven Chapman and President of Clinical Diagnostics Solomon Moshkevich — sold a combined $865K in open-market shares on September 1, 2026. While the dollar amount is trivial relative to Natera's $46.9B market cap (0.002%), the involvement of both the CEO and a key division president in the same window warrants attention, though insider sales at this scale are typically liquidity-driven and not predictive of near-term downside.

Key Financial Metrics

Direction
selling
Total Value
$865.0K
Insiders
2

Key Facts

  • CEO Steven Chapman sold 1,698 shares at $320.99 for $545K on 2026-09-01
  • President Solomon Moshkevich sold 1,000 shares at $319.76 for $320K on 2026-09-01
  • Total cluster value of $865K represents ~0.002% of Natera's $46.9B market cap
  • Both sales were open-market transactions, not 10b5-1 plan sales
  • No insider buying activity in the cluster window

Financial Impact

$865K in insider sales, negligible relative to $46.9B market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if executives perceive valuation as stretched
  • No insider buying to offset the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
87% bullish (30 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NTRA-1788485730285
35 reports for NTRA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+1▲ +3.43%Feb 28, 2026
Filters
Rows
Reports for NTRA — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 3/10
$328.18 $341.79▲ +4.15%▲ +5.36%$410.35 (+25.04%)
Aug 29, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$321.96 $328.59▼ −2.06%▼ −2.20%$410.35 (−27.45%)
Aug 15, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$314.18 $327.72▲ +4.31%▲ +5.50%$410.35 (+30.61%)
Aug 8, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$318.35 $314.18▼ −1.31%▼ −1.26%$410.35 (+28.90%)
Aug 6, 2026
8w ago
Insider Cluster
BEARISH ★ 4/10
$265.38 $310.78▼ −17.11%▼ −15.89%$410.35 (−54.63%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$269.66 $265.38▼ −1.59%▼ −5.21%$410.35 (+52.17%)
Jul 18, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$262.63 $261.99▼ −0.24%▲ +0.18%$410.35 (+56.25%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$269.83 $264.69▼ −1.90%▼ −0.23%$410.35 (+52.08%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.85 $269.83▼ −4.26%▼ −4.13%$410.35 (+45.59%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.27 $272.66▼ −3.06%▼ −3.61%$410.35 (+45.89%)
Showing 10 of 35

US Market Status

Market Closed — Opens Mon (65h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 4, 2026